Paper33336364
Physicochemical properties of dihydromyricetin and the effects of ascorbic acid on its stability and bioavailability.
Sun CC and 3 others. J Sci Food Agric, 2021. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Physicochemical properties of dihydromyricetin and the effects of ascorbic acid on its stability and bioavailability. Papers, record 33336364. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33336364
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Physicochemical properties of dihydromyricetin and the effects of ascorbic acid on its stability and bioavailability.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ascorbic Acid | Major topic |
| Flavonols | Major topic |
| Animals | |
| Biological Availability | |
| Chromatography, High Pressure Liquid | |
| Drug Stability | |
| Female | |
| Kinetics | |
| Rats | |
| Rats, Sprague-Dawley | |
| Solubility |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 31760461 | National Natural Science Foundation of China | PubMed |
Source PubMed
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42625354 | Review of the Composition and Antimicrobial Roles of Extracts of Vine Tea (Ampelopsis grossedentata). | Med Sci Monit | 2026 | https://conductscience.org/library/papers/42625354 | PubMed |
| 41792133 | The natural flavonoid dihydromyricetin targets senescent cells via PRDX2 and alleviates age-related diseases. | Nat Commun | 2026 | https://conductscience.org/library/papers/41792133 | PubMed |
| 41398910 | Development and evaluation of a novel nebulized dihydromyricetin formulation: enhanced pulmonary delivery and pharmacokinetic properties. | Respir Res | 2025 | https://conductscience.org/library/papers/41398910 | PubMed |
| 40757164 | A multifunctional dihydromyricetin-loaded hydrogel for the sequential modulation of diabetic wound healing and glycemic control. | Burns Trauma | 2025 | https://conductscience.org/library/papers/40757164 | PubMed |
| 40740995 | Pharmacological mechanisms and potential clinical applications of Dihydromyricetin in neurological disorders. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40740995 | PubMed |
| 40538991 | Orange-Fleshed Sweet Potatoes, Grain Amaranth, Biofortified Beans, and Maize Composite Flour Formulation Optimization and Product Characterization. | Food Sci Nutr | 2025 | https://conductscience.org/library/papers/40538991 | PubMed |
| 40076792 | Molecular Mechanism of Vine Tea Dihydromyricetin Extract on Alleviating Glucolipid Metabolism Disorder in db/db Mice: Based on Liver RNA-Seq and TLR4/MyD88/NF-κB Pathway. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40076792 | PubMed |
| 39227809 | Dihydromyricetin suppresses endothelial NLRP3 inflammasome activation and attenuates atherogenesis by promoting mitophagy. | Lipids Health Dis | 2024 | https://conductscience.org/library/papers/39227809 | PubMed |
| 39206852 | Design, synthesis, and biological activity evaluation of dihydromyricetin derivatives against SARS-CoV-2-Omicron virus. | J Enzyme Inhib Med Chem | 2024 | https://conductscience.org/library/papers/39206852 | PubMed |
| 38628627 | Multiple molecular and cellular mechanisms of the antitumour effect of dihydromyricetin (Review). | Biomed Rep | 2024 | https://conductscience.org/library/papers/38628627 | PubMed |
| 36618100 | Structure-activity relationship of dietary flavonoids on pancreatic lipase. | Curr Res Food Sci | 2023 | https://conductscience.org/library/papers/36618100 | PubMed |
| 36146939 | Strategic developments in the drug delivery of natural product dihydromyricetin: applications, prospects, and challenges. | Drug Deliv | 2022 | https://conductscience.org/library/papers/36146939 | PubMed |
| 35312865 | Curdlan production from cassava starch hydrolysates by Agrobacterium sp. DH-2. | Bioprocess Biosyst Eng | 2022 | https://conductscience.org/library/papers/35312865 | PubMed |
| 35154679 | LC-ESI-QTOF/MS characterization of antimicrobial compounds with their action mode extracted from vine tea (Ampelopsis grossedentata) leaves. | Food Sci Nutr | 2022 | https://conductscience.org/library/papers/35154679 | PubMed |
| 35115939 | Mechanism of Dihydromyricetin on Inflammatory Diseases. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/35115939 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33336364
GET https://conductscience.org/api/papers/v1/33336364/authors